Global private equity and venture capital news and research

VC-backed pharma developer Flexion Therapeutics files for $86m IPO

10 Jan 2014

Venture capital-backed pharmaceutical company Flexion Therapeutics could raise up to $86m for its IPO on the Nasdaq.

BMO Capital Markets and Wells Fargo Securities are acting as joint book-running managers.

Flexion is company developing innovative therapeutics for musculoskeletal disorders. The company is currently advancing a portfolio of drug candidates that together have the potential to treat pain from mild, moderate and severe forms of osteoarthritis.

In 2009 the company completed a $33m Series A financing round led by Versant Ventures and included founding investors 5AM Ventures and Sofinnova Partners.

Copyright © 2014 AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016